Unconventional Cancer Drug Delivery: Bread, Chewing Gum, and More
This article explores innovative and unconventional methods for delivering cancer therapeutics, aiming to improve drug accumulation at target sites while reducing off-target toxicity. Researchers from Stony Brook University developed a bread-based oral vaccine using a modified Listeria monocytogenes strain to combat colorectal cancer. In murine models, this approach successfully induced robust CD8 T cell responses and controlled tumor growth when combined with immune checkpoint inhibitors, offering hope for patients with advanced disease. Additionally, an ex vivo study by the University of Pennsylvania demonstrated that bioengineered chewing gum containing antiviral or antibacterial agents could reduce carcinogenic microbes in the mouth, showing potential for preventing or treating oral cancer. The report highlights how these unusual delivery vectors, ranging from food items to biological fluids, represent a shift in cancer research towards more targeted and effective immunotherapy strategies. These developments underscore the importance of delivery mechanisms in maximizing the efficacy of novel treatments, particularly for gastrointestinal and oral cancers where traditional intravenous methods face limitations.
Wire timeline
Unconventional Cancer Drug Delivery: Bread, Chewing Gum, and More
This article explores innovative and unconventional methods for delivering cancer therapeutics, aiming to improve drug accumulation at target sites while reducing off-target toxicity. Researchers from Stony Brook University developed a bread-based oral vaccine using a modified Listeria monocytogenes strain to combat colorectal cancer. In murine models, this approach successfully induced robust CD8 T cell responses and controlled tumor growth when combined with immune checkpoint inhibitors, offering hope for patients with advanced disease. Additionally, an ex vivo study by the University of Pennsylvania demonstrated that bioengineered chewing gum containing antiviral or antibacterial agents could reduce carcinogenic microbes in the mouth, showing potential for preventing or treating oral cancer. The report highlights how these unusual delivery vectors, ranging from food items to biological fluids, represent a shift in cancer research towards more targeted and effective immunotherapy strategies. These developments underscore the importance of delivery mechanisms in maximizing the efficacy of novel treatments, particularly for gastrointestinal and oral cancers where traditional intravenous methods face limitations.
BioTechniques